文献速递新生儿儿童神经与发育行为

新生儿戒断综合征的诊断编码与病例定义准确性评估

Diagnosis Codes and Case Definitions for Neonatal Abstinence Syndrome.
PubMed 文献 · Pediatrics · 2020-01-01

佛罗里达出生缺陷登记处对2016年出生、编码为P96.1和/或P04.49的婴儿进行病历回顾,评估国际疾病分类第10版临床修改(ICD-10-CM)编码的阳性预测值(PPV)及州与领地流行病学家委员会(CSTE)病例定义的敏感性。结果显示P96.1编码PPV高达95.3%,而P04.49仅13.2%;CSTE定义整体PPV更低(47.8%),且将60.7%有明确临床戒断体征的病例判为无NAS,提示该定义低估患病率。

要点

  • P96.1编码诊断新生儿戒断综合征(NAS)准确性高,PPV达95.3%。
  • P04.49编码准确性低,PPV仅13.2%,不宜单独用于监测。
  • CSTE病例定义敏感性不足,低估NAS患病率。

核心结论

  • 仅P96.1编码显示高准确性,P04.49编码及CSTE病例定义准确性低。
  • 病例定义与监测方法不一致可能导致错误的比较和结论。

研究设计与样本

  • 佛罗里达出生缺陷登记处对2016年出生、编码为P96.1和/或P04.49的婴儿进行病历回顾。
  • 共回顾128例仅P96.1、68例仅P04.49、7例同时有两者编码的病例。
  • 缺乏NAS金标准定义,使用临床数据按佛罗里达和CSTE定义分类,计算编码特异性PPV。

主要发现

  • 按佛罗里达定义,总体PPV为68%,P96.1为95.3%,P04.49为13.2%。
  • 按CSTE定义,总体PPV为47.8%,各编码PPV均更低。
  • CSTE定义判为无NAS的病例中,60.7%有明确的NAS临床体征。
  • 在本样本中,CSTE病例定义低估了NAS患病率。

关键数值与推荐

  • 佛罗里达定义下P96.1编码PPV为95.3%,P04.49编码PPV为13.2%。
  • CSTE定义下总体PPV为47.8%。
  • CSTE定义判为无NAS的病例中60.7%有明确临床体征。

临床怎么用

  • 监测和研究应优先使用P96.1编码,谨慎单独使用P04.49编码。
  • 采用CSTE病例定义时需注意其可能低估NAS患病率。
  • 应统一NAS病例定义和监测方法以保证可比性。

局限性

  • 缺乏NAS金标准定义,病例分类依赖临床数据。
  • 样本仅来自佛罗里达2016年出生婴儿,代表性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The increase in neonatal abstinence syndrome (NAS) has underscored the need for NAS surveillance programs, but many rely on passive surveillance using unverified diagnosis codes. Few studies have evaluated the validity of these codes, and no study has assessed the recently proposed Council of State and Territorial Epidemiologists (CSTE) case definition. The Florida Birth Defects Registry investigated the accuracy of International Classification of Diseases, 10th Revision, Clinical Modification codes related to NAS (P96.1 and P04.49) and assessed the sensitivity of the CSTE case definition. METHODS: We identified a sample of infants born during 2016 coded with P96.1 and/or P04.49. Record review was completed for 128 cases coded with P96.1, 68 with P04.49, and 7 with both codes. Lacking consensus regarding a gold standard definition of NAS, we used clinical data to classify each case using the Florida and CSTE definitions. The code-specific accuracy was measured by using the positive predictive value (PPV). The clinical characteristics indicative of NAS were compared for case classification based on both definitions. RESULTS: By using the Florida definition, the overall PPV was 68% but varied by code: 95.3% for P96.1 and 13.2% for P04.49. The overall (47.8%) and code-specific PPVs were lower by using the CSTE definition. Comparison of clinical characteristics demonstrated that 60.7% of cases classified as no NAS by using the CSTE definition had robust clinical signs of NAS. In our sample, the CSTE case definition underestimated NAS prevalence. CONCLUSIONS: Only the P96.1 International Classification of Diseases, 10th Revision, Clinical Modification code displayed high accuracy. Discordance in NAS case definitions and surveillance methodologies may result in erroneous comparisons and conclusions that negatively impact NAS-related surveillance and research.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Elmore AL, Tanner JP, Lowry J, et al. Diagnosis Codes and Case Definitions for Neonatal Abstinence Syndrome. Pediatrics. 2020. PMID: 32848030. doi:10.1542/peds.2020-0567

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。